Advanced phase chronic myeloid leukaemia (CML) in the tyrosine kinase inhibitor era - a report from the Swedish CML register
详细信息 查看全文
- 作者：Stina Sö ; derlund ; Torsten Dahlé ; n ; Fredrik Sandin ; Ulla Olsson-Strö ; mberg ; Maria Creignou ; Arta Dreimane ; Anna Lü ; bking ; Berit Markevä ; rn ; Anders Sjä ; lander ; Hans Wadenvik ; Leif Stenke ; Johan Richter and Martin Hö ; glund
- 刊名：European Journal of Haematology
- 出版年：2017
- 出版时间：January 2017
- 年：2017
- 卷：98
- 期：1
- 页码：57-66
- 全文大小：280K
- ISSN：1600-0609
文摘
The primary goal in management of chronic phase (CP) chronic myeloid leukaemia (CML) is to prevent disease progression to accelerated phase (AP) or blast crisis (BC). We have evaluated progression rates in a decentralised healthcare setting and characterised patients progressing to AP/BC on TKI treatment.